New lupus drug aims to tame rogue immune system

NCT ID NCT05624749

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a monthly injection called ianalumab to standard lupus treatment helps control the disease better than standard treatment alone. Researchers are enrolling 288 people with active systemic lupus erythematosus to see if the drug reduces disease flare-ups and allows patients to use lower doses of steroids. The trial is in its final testing phase to determine if the treatment is effective and safe.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Accurate Clinical Research

Lake Charles, Louisiana, 70601, United States
Advanced Medical Research

La Palma, California, 90623, United States
Ahmed Arif Medical Research Center

Grand Blanc, Michigan, 48439, United States
Bluegrass Community Research Inc

Lexington, Kentucky, 40504, United States
Emory University

Atlanta, Georgia, 30307, United States
Homestead Assoc In Research Inc

Homestead, Florida, 33033, United States
IRIS Research and Development

Plantation, Florida, 33324, United States
Novartis Investigative Site

La Plata, Buenos Aires, B1900AWT, Argentina
Novartis Investigative Site

Quilmes, Buenos Aires, 1878, Argentina
Novartis Investigative Site

San Miguel, Buenos Aires, B1663GKT, Argentina
Novartis Investigative Site

San Miguel, Tucumán Province, T4000CBC, Argentina
Novartis Investigative Site

Caba, C1015ABO, Argentina
Novartis Investigative Site

Caba, C1426, Argentina
Novartis Investigative Site

San Miguel de Tucumán, 4000, Argentina
Novartis Investigative Site

Maroochydore, Queensland, 4558, Australia
Novartis Investigative Site

St Leonards, 2065, Australia
Novartis Investigative Site

Concepción, Bio Bio, 4070280, Chile
Novartis Investigative Site

Valdivia, Los Ríos Region, 5110683, Chile
Novartis Investigative Site

Santiago, RM, 7500588, Chile
Novartis Investigative Site

Santiago, Santiago Metropolitan, 7500710, Chile
Novartis Investigative Site

Medellín, Antioquia, 050001, Colombia
Novartis Investigative Site

Barranquilla, Atlántico, 080002, Colombia
Novartis Investigative Site

Barranquilla, Atlántico, 080020, Colombia
Novartis Investigative Site

Chía, Cundinamarca, 250001, Colombia
Novartis Investigative Site

Bucaramanga, Santander Department, 680003, Colombia
Novartis Investigative Site

Cali, Valle del Cauca Department, 760046, Colombia
Novartis Investigative Site

Bogotá, 111211, Colombia
Novartis Investigative Site

Grenoble, 38043, France
Novartis Investigative Site

Montpellier, 34295, France
Novartis Investigative Site

Paris, 75013, France
Novartis Investigative Site

Paris, 75014, France
Novartis Investigative Site

Paris, 75018, France
Novartis Investigative Site

Toulouse, 31054, France
Novartis Investigative Site

Toulouse, 31059, France
Novartis Investigative Site

Tours, 37044, France
Novartis Investigative Site

Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
Novartis Investigative Site

Cologne, North Rhine-Westphalia, 50937, Germany
Novartis Investigative Site

Leipzig, Saxony, 04103, Germany
Novartis Investigative Site

Herne, 44649, Germany
Novartis Investigative Site

Mainz, 55131, Germany
Novartis Investigative Site

Ahmedabad, Gujarat, 380006, India
Novartis Investigative Site

Ahmedabad, Gujarat, 380015, India
Novartis Investigative Site

Kozhikode, Kerala, 673008, India
Novartis Investigative Site

Kolhāpur, Maharashtra, 416001, India
Novartis Investigative Site

Nagpur, Maharashtra, 441108, India
Novartis Investigative Site

Nashik, Maharashtra, 422101, India
Novartis Investigative Site

Pune, Maharashtra, 411001, India
Novartis Investigative Site

Pune, Maharashtra, 411007, India
Novartis Investigative Site

New Delhi, National Capital Territory of Delhi, 110060, India
Novartis Investigative Site

Dehradun, Uttarakhand, 248001, India
Novartis Investigative Site

New Delhi, 110029, India
Novartis Investigative Site

New Delhi, 110075, India
Novartis Investigative Site

Ancona, AN, 60126, Italy
Novartis Investigative Site

Cona, FE, 44124, Italy
Novartis Investigative Site

Padua, PD, 35128, Italy
Novartis Investigative Site

Pisa, PI, 56126, Italy
Novartis Investigative Site

Roma, RM, 00152, Italy
Novartis Investigative Site

Torino, TO, 10128, Italy
Novartis Investigative Site

Naples, 80147, Italy
Novartis Investigative Site

Seremban, Negeri Sembilan, 70300, Malaysia
Novartis Investigative Site

Ipoh, Perak, 30450, Malaysia
Novartis Investigative Site

Kuala Lumpur, 59100, Malaysia
Novartis Investigative Site

Selangor Darul Ehsan, 68100, Malaysia
Novartis Investigative Site

León, Guanajuato, 37160, Mexico
Novartis Investigative Site

Guadalajara, Jalisco, 44160, Mexico
Novartis Investigative Site

Mexico City, Mexico City, 06700, Mexico
Novartis Investigative Site

Morelia, Michoacán, 58000, Mexico
Novartis Investigative Site

Mérida, Yucatán, 97000, Mexico
Novartis Investigative Site

Mérida, Yucatán, 97070, Mexico
Novartis Investigative Site

México, 07760, Mexico
Novartis Investigative Site

Cluj-Napoca, Cluj, 400006, Romania
Novartis Investigative Site

Afumaţi, Ilfov, 077010, Romania
Novartis Investigative Site

Brasov, 500283, Romania
Novartis Investigative Site

Bucharest, 011172, Romania
Novartis Investigative Site

Gwangju Gwangyeoksi, Gwangju, 61748, South Korea
Novartis Investigative Site

Seoul, 04763, South Korea
Novartis Investigative Site

Seoul, 06591, South Korea
Novartis Investigative Site

Kaohsiung City, 83301, Taiwan
Novartis Investigative Site

Taichung, 40447, Taiwan
Novartis Investigative Site

Taichung, 407219, Taiwan
Novartis Investigative Site

Taipei, 10002, Taiwan
Novartis Investigative Site

Taipei, 11217, Taiwan
Novartis Investigative Site

Taoyuan District, 33305, Taiwan
Novartis Investigative Site

Leeds, West Yorkshire, LS7 4SA, United Kingdom
Novartis Investigative Site

Doncaster, DN2 5LT, United Kingdom
Novartis Investigative Site

Leicester, LE1 5WW, United Kingdom
Novel Research LLC

Bellaire, Texas, 77401, United States
Pinnacle Research Group LLC

Anniston, Alabama, 36207-5710, United States
Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States
UMC New Orleans

New Orleans, Louisiana, 70112, United States
University Of Maryland

Baltimore, Maryland, 21201, United States
University of California LA

Los Angeles, California, 90095, United States
Washington Univ School Of Medicine

St Louis, Missouri, 63110, United States
West Tennessee Research Institute

Jackson, Tennessee, 38305, United States
Willow Rheumatology Wellness

Willowbrook, Illinois, 60527, United States

Conditions

Explore the condition pages connected to this study.

SYSTEMIC LUPUS ERYTHEMATOSUS